Concept
Our Strategy and Results
Pursuing the Essence
The team members full of expertise, curiosity, flexibility, judgment, and execution power never settle for the status quo, never give up, and tirelessly tackle problem-solving every day.
Developing Trace Analysis
Using high-performance, state-of-the-art analytical instruments, the team members are developing efficient analytical methods to rapidly and accurately measure "trace amounts of nitrosoamines contained in medicines," ensuring that products are delivered to the market without any blemishes.
Creation of NOx Removal System
We have developed the excellent NOx removal system by considering every possible measure and through trial and error to reduce NOx to a few ppb levels (akin to finding one person in a country with a population of one billion).
Refine APIs/DPs Manufacturing Process
Manufacturing methods, equipment, and environment for Active Pharmaceutical Ingredients (APIs) and Drug Products (DPs) are carefully reviewed one by one to reliably and proactively prevent the contamination of nitrosoamines.
Refine Packaging Materials and Storage Methods
We select packaging materials that ensure no contamination with nitrosoamines can occur, confidently delivering safe and secure pharmaceuticals to the market.
R&D News
-
2025 Academic Award for Division of Particulate Design and Preparations.
The Offensive and Defensive Battle Against Nitrosoamines —The Path from Investigation of cause to Implementation— - Towa Pharmaceutical’s Research paper on the reduction of nitroso-atomoxetine contamination to 0.097 ppm under NOx-free environments was published in ACS Organic Process Research & Development
- Dr. Osamu Uchikawa made the seminar talk in the INTERPHEX Week Tokyo 2025
- Towa Pharmaceutical's Research paper on nitrosoamine-control strategy, The Towa Amine Approach, was published in ACS Omega
- Towa Pharmaceutical’s Research paper on lowering nitrogen oxides in the atmosphere, a contributing factor of nitrosoamine formation, was published in ACS Organic Process Research & Development
- Towa Pharmaceutical's Research paper on new analytical method for N-Nitroso Duloxetine was published in ACS Omega
- Towa Pharmaceutical's Research paper on mechanistic study clarifying carcinogenic NDMA formation was published in ACS(American Chemical Society) Organic Process Research & Development (update: Nov 30, 2023)
Interview
Ph.D.
